Nasdaq
$0.5870▼ 0.68%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $45.1MShares out 76.9M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
10- 10.16After-hours26.10.17 05:308-KKey event#●●●#●●●
Envoy Medical, Inc.
Envoy Medical held a special meeting of stockholders on October 12, 2026, and approved a proposal for a reverse stock split. The Board of Directors has been authorized to implement one or more reverse stock splits at a ratio between 1-for-5 and 1-for-25 at any time on or before December 31, 2026.…more
$0.5870-0.68%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.7Pre-market26.10.07 22:008-KKey event
Envoy Medical, Inc.
Envoy Medical has entered into a dismissal agreement regarding litigation with Atlas Merchant Capital SPAC Fund I LP in the Delaware Court of Chancery. Under the terms, all claims will be dismissed with prejudice, and the company is not required to make any payments to Atlas, effectively resolving the litigation.…more
$0.5870-0.68%vs prev closeView filingShare - 9.14After-hours26.09.15 05:25SCHEDULE 13G/AOwnership
Envoy Medical, Inc.
Alta Partners LLC has filed a SCHEDULE 13G/A regarding their beneficial ownership in Envoy Medical, Inc. This filing provides an update on the major shareholder's equity position in the company.…more
$0.5870-0.68%vs prev closeView filingShare
9 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 3d agoPre-market26.10.22 21:36Bullish#●●●
Envoy Medical Announces 1-for-10 Reverse Stock Split
Envoy Medical will implement a 1-for-10 reverse stock split of its Class A common stock effective October 26, 2026. This corporate action is often taken to maintain listing compliance and may signal underlying financial pressure.…more
$0.5870-0.68%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 5d agoPre-market26.10.20 21:37
●●●●●●●● ●●●●● ●●●●●●
Envoy Medical has surpassed the six-month follow-up milestone in its pivotal clinical trial for the fully implanted Acclaim cochlear implant. The company remains on track to submit its final PMA module to the FDA by the end of Q2 2027.…more
$0.5870-0.68%vs prev closeShareBenzinga - 10.12Pre-market26.10.12 21:33
●●●●●●●● ●●●●● ●●●●●●
Envoy Medical has submitted the second of four modules for its Acclaim cochlear implant's PMA application to the FDA. The company remains on track to submit the final clinical module by the second quarter of 2027.…more
$0.5870-0.68%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report